Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.

IMPORTANCE Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest. OBJECTIVE To compare site of death, health care utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using administrative and registry data from 2010. Participants were decedents older than 65 years who died with cancer. Secondary analyses included decedents of any age, decedents older than 65 years with lung cancer, and decedents older than 65 years in the United States and Germany from 2012. MAIN OUTCOMES AND MEASURES Deaths in acute care hospitals, 3 inpatient measures (hospitalizations in acute care hospitals, admissions to intensive care units, and emergency department visits), 1 outpatient measure (chemotherapy episodes), and hospital expenditures paid by insurers (commercial or governmental) during the 180-day and 30-day periods before death. Expenditures were derived from country-specific methods for costing inpatient services. RESULTS The United States (cohort of decedents aged >65 years, N = 211,816) and the Netherlands (N = 7216) had the lowest proportion of decedents die in acute care hospitals (22.2.% and 29.4%, respectively). A higher proportion of decedents died in acute care hospitals in Belgium (N = 21,054; 51.2%), Canada (N = 20,818; 52.1%), England (N = 97,099; 41.7%), Germany (N = 24,434; 38.3%), and Norway (N = 6636; 44.7%). In the last 180 days of life, 40.3% of US decedents had an intensive care unit admission compared with less than 18% in other reporting nations. In the last 180 days of life, mean per capita hospital expenditures were higher in Canada (US $21,840), Norway (US $19,783), and the United States (US $18,500), intermediate in Germany (US $16,221) and Belgium (US $15,699), and lower in the Netherlands (US $10,936) and England (US $9342). Secondary analyses showed similar results. CONCLUSIONS AND RELEVANCE Among patients older than 65 years who died with cancer in 7 developed countries in 2010, end-of-life care was more hospital-centric in Belgium, Canada, England, Germany, and Norway than in the Netherlands or the United States. Hospital expenditures near the end of life were higher in the United States, Norway, and Canada, intermediate in Germany and Belgium, and lower in the Netherlands and England. However, intensive care unit admissions were more than twice as common in the United States as in other countries.

[1]  Cancer care in the United States: identifying end-of-life cohorts. , 2009, Journal of palliative medicine.

[2]  L. Deliens,et al.  A Public Health Perspective on End of Life Care Joachim Cohen A Public Health Perspective on End of Life Care Luc Deliens Oxford University Press £34.99 272pp 9780199599400 9780199599400 [Formula: see text]. , 2012, Nursing older people.

[3]  L. Stepp Approaching Death: Improving Care at the End of Life , 1998, Annals of Internal Medicine.

[4]  S. Kaasa,et al.  Which patients with cancer die at home? A study of six European countries using death certificate data. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Berke,et al.  End-of-life care for Medicare beneficiaries with cancer is highly intensive overall and varies widely. , 2012, Health affairs.

[6]  H. Wunsch,et al.  Clinical review: International comparisons in critical care - lessons learned , 2012, Critical Care.

[7]  E. Emanuel Cost savings at the end of life. What do the data show? , 1996, JAMA.

[8]  L. Deliens,et al.  Quality indicators for palliative care: update of a systematic review. , 2013, Journal of pain and symptom management.

[9]  B. Onwuteaka-Philipsen,et al.  End-of-life communication: a retrospective survey of representative general practitioner networks in four countries. , 2014, Journal of pain and symptom management.

[10]  Reinhard Busse,et al.  DRG-based hospital payment systems and technological innovation in 12 European countries. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  E. Emanuel,et al.  Managed care, hospice use, site of death, and medical expenditures in the last year of life. , 2002, Archives of internal medicine.

[12]  Pall Med,et al.  Dying in America: improving quality and honoring individual preferences near the end of life. , 2015, Military medicine.

[13]  Does healthcare infrastructure have an impact on delay in diagnosis and survival? , 2012, Health policy.

[14]  C. Zimmermann,et al.  Aggressive treatment and palliative care at the end of life , 2012 .

[15]  D. Haugen,et al.  Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Dhruv B. Sharma,et al.  Regional variation in spending and survival for older adults with advanced cancer. , 2013, Journal of the National Cancer Institute.

[17]  Geir Godager,et al.  Hospital expenses towards the end of life. , 2013, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[18]  E. Emanuel,et al.  Place of death: U.S. trends since 1980. , 2004, Health affairs.

[19]  Melonie P. Heron Deaths: leading causes for 2010. , 2013, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[20]  E. Emanuel A review of the ethical and legal aspects of terminating medical care. , 1988, The American journal of medicine.

[21]  A. Hoes,et al.  Routine health insurance data for scientific research: potential and limitations of the Agis Health Database. , 2011, Journal of clinical epidemiology.

[22]  C. Earle,et al.  Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Reinhard Busse,et al.  Hospital payment based on diagnosis-related groups differs in Europe and holds lessons for the United States. , 2013, Health affairs.

[24]  J. Herzstein US Health in International Perspective: Shorter Lives, Poorer Health , 2013 .

[25]  P. Schreyer,et al.  Comparing Hospital and Health Prices and Volumes Internationally: Results of a Eurostat/OECD Project , 2014 .

[26]  P. Marik The Cost of Inappropriate Care at the End of life , 2015, The American journal of hospice & palliative care.

[27]  J. Lubitz,et al.  Long-term trends in Medicare payments in the last year of life. , 2010, Health services research.

[28]  D M Eddy,et al.  Comparing benefits and harms: the balance sheet. , 1990, JAMA.

[29]  M. Field,et al.  Approaching death: improving care at the end of life. , 2011, Health progress.

[30]  D. Currow,et al.  Hospital and emergency department use in the last year of life: a baseline for future modifications to end‐of‐life care , 2011, The Medical journal of Australia.

[31]  A. Jemal,et al.  International variation in prostate cancer incidence and mortality rates. , 2012, European urology.

[32]  Vincent Mor,et al.  Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. , 2013, JAMA.

[33]  I. Higginson,et al.  Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. , 2000, Journal of palliative medicine.

[34]  I. Finlay,et al.  Improving palliative care for cancer. , 2003, The Lancet. Oncology.

[35]  J. Skinner,et al.  Racial and Ethnic Differences in Preferences for End-of-Life Treatment , 2009, Journal of General Internal Medicine.

[36]  Jason Roy,et al.  Where People Die: A Multilevel Approach to Understanding Influences on Site of Death in America , 2007, Medical care research and review : MCRR.